DKCM
AEON icon

Davidson Kempner Capital Management’s AEON Biopharma AEON Stock Holding History

Davidson Kempner Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,251
Closed -$94.6K – 222
2024
Q2 		$94.6K Buy
+1,251
New +$298K ﹤0.01% 186
2023
Q1 		– Sell
-17,636
Closed -$12.8M – 379
2022
Q4 		$12.8M Hold
17,636
– – 0.24% 93
2022
Q3 		$12.5M Hold
17,636
– – 0.22% 90
2022
Q2 		$12.4M Hold
17,636
– – 0.21% 97
2022
Q1 		$12.4M Hold
17,636
– – 0.16% 111
2021
Q4 		$12.3M Hold
17,636
– – 0.18% 103
2021
Q3 		$12.4M Buy
17,636
+275
+2% +$192K 0.18% 107
2021
Q2 		$12.1M Buy
+17,361
New +$12.1M 0.09% 139

Other funds holding AEON

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Davidson Kempner Capital Management's AEON Position: Q3 2024 in Review

Davidson Kempner Capital Management sold out of AEON Biopharma (AEON) in Q3 2024, closing a stake of 1,251 shares — an estimated $94.6K sold.

Davidson Kempner Capital Management first reported a position in AEON in Q2 2021 and held it in 8 quarters. The position peaked at $12.8M in Q4 2022. 30 funds tracked by Wall St. Rank hold AEON as of Q3 2024.

  • Davidson Kempner Capital Management reported no remaining AEON Biopharma position as of Q3 2024 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 1,251 AEON Biopharma shares in Q3 2024, an estimated $94.6K.
  • Davidson Kempner Capital Management first reported a position in AEON Biopharma in Q2 2021 and held it in 8 quarters.
  • Davidson Kempner Capital Management's AEON Biopharma position peaked at $12.8M in Q4 2022.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2024.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.